Influenza A Viral Infections Drug Development Pipeline Review, 2018

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 10
2.1 Influenza A Viral Infections Report Coverage 10
2.2 Influenza A Virus, H3N2 Subtype Infections – Overview 10
2.3 Influenza A Virus, H1N1 Subtype Infections – Overview 10
2.4 Influenza A Virus, H5N1 Subtype Infections – Overview 10
2.5 Influenza A Virus, H7N9 Subtype Infections – Overview 10
3 Therapeutics Development 11
3.1 Influenza A Virus, H3N2 Subtype Infections 11
3.2 Influenza A Virus, H1N1 Subtype Infections 19
3.3 Influenza A Virus, H5N1 Subtype Infections 31
3.4 Influenza A Virus, H7N9 Subtype Infections 41
4 Therapeutics Assessment 48
4.1 Influenza A Virus, H3N2 Subtype Infections 48
4.2 Influenza A Virus, H1N1 Subtype Infections 55
4.3 Influenza A Virus, H5N1 Subtype Infections 62
4.4 Influenza A Virus, H7N9 Subtype Infections 69
5 Companies Involved in Therapeutics Development 75
5.1 Influenza A Virus, H3N2 Subtype Infections 75
5.2 Influenza A Virus, H1N1 Subtype Infections 89
5.3 Influenza A Virus, H5N1 Subtype Infections 114
5.4 Influenza A Virus, H7N9 Subtype Infections 130
6 Dormant Projects 140
6.1 Influenza A Virus, H3N2 Subtype Infections 140
6.2 Influenza A Virus, H1N1 Subtype Infections 142
6.3 Influenza A Virus, H5N1 Subtype Infections 146
6.4 Influenza A Virus, H7N9 Subtype Infections 151
7 Discontinued Products 152
7.1 Influenza A Virus, H3N2 Subtype Infections 152
7.2 Influenza A Virus, H1N1 Subtype Infections 153
7.3 Influenza A Virus, H5N1 Subtype Infections 153
8 Product Development Milestones 154
8.1 Influenza A Virus, H3N2 Subtype Infections 154
8.2 Influenza A Virus, H1N1 Subtype Infections 160
8.3 Influenza A Virus, H5N1 Subtype Infections 174
8.4 Influenza A Virus, H7N9 Subtype Infections 185
9 Appendix 187
9.1 Methodology 187
9.2 Coverage 187
9.3 Secondary Research 187
9.4 Primary Research 187
9.5 Expert Panel Validation 187
9.6 Contact Us 188
9.7 Disclaimer 188

List of Tables
1.1 List of Tables
Table 1: Number of Products under Development for Influenza A Virus, H3N2 Subtype Infections 11
Table 2: Number of Products under Development by Companies Influenza A Virus, H3N2 Subtype Infections 12
Table 3: Number of Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections 14
Table 4: Products under Development by Companies Influenza A Virus, H3N2 Subtype Infections 15
Table 5: Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections 18
Table 6: Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections 19
Table 7: Number of Products under Development by Companies, Influenza A Virus, H1N1 Subtype Infections 21
Table 8: Number of Products under Development by Universities/Institutes, Influenza A Virus, H1N1 Subtype Infections 23
Table 9: Products under Development by Companies, Influenza A Virus, H1N1 Subtype Infections 24
Table 10: Products under Development by Universities/Institutes, Influenza A Virus, H1N1 Subtype Infections 30
Table 11: Number of Products under Development for Influenza A Virus, H5N1 Subtype Infections 32
Table 12: Number of Products under Development by Companies, Influenza A Virus, H5N1 Subtype Infections 34
Table 13: Number of Products under Development by Universities/Institutes, Influenza A Virus, H5N1 Subtype Infections 36
Table 14: Products under Development by Companies, Influenza A Virus, H5N1 Subtype Infections 37
Table 15: Products under Development by Universities/Institutes, Influenza A Virus, H5N1 Subtype Infections 40
Table 16: Number of Products under Development for Influenza A Virus, H7N9 Subtype Infections 41
Table 17: Number of Products under Development by Companies, Influenza A Virus, H7N9 Subtype Infections 43
Table 18: Number of Products under Development by Universities/Institutes, Influenza A Virus, H7N9 Subtype Infections 44
Table 19: Products under Development by Companies, Influenza A Virus, H7N9 Subtype Infections 45
Table 20: Products under Development by Universities/Institutes, Influenza A Virus, H7N9 Subtype Infections 47
Table 21: Number of Products by Stage and Target, Influenza A Virus, H3N2 Subtype Infections 49
Table 22: Number of Products by Stage and Mechanism of Action, Influenza A Virus, H3N2 Subtype Infections 51
Table 23: Number of Products by Stage and Route of Administration, Influenza A Virus, H3N2 Subtype Infections 53
Table 24: Number of Products by Stage and Molecule Type, Influenza A Virus, H3N2 Subtype Infections 55
Table 25: Number of Products by Stage and Target, Influenza A Virus, H3N2 Subtype Infections 56
Table 26: Number of Products by Stage and Mechanism of Action, Influenza A Virus, H3N2 Subtype Infections 58
Table 27: Number of Products by Stage and Route of Administration, Influenza A Virus, H3N2 Subtype Infections 60
Table 28: Number of Products by Stage and Molecule Type, Influenza A Virus, H3N2 Subtype Infections 62
Table 29: Number of Products by Stage and Target, Influenza A Virus, H5N1 Subtype Infections 63
Table 30: Number of Products by Stage and Mechanism of Action, Influenza A Virus, H5N1 Subtype Infections 65
Table 31: Number of Products by Stage and Route of Administration, Influenza A Virus, H5N1 Subtype Infections 67
Table 32: Number of Products by Stage and Molecule Type, Influenza A Virus, H5N1 Subtype Infections 68
Table 33: Number of Products by Stage and Target, Influenza A Virus, H7N9 Subtype Infections 70
Table 34: Number of Products by Stage and Mechanism of Action, Influenza A Virus, H7N9 Subtype Infections 71
Table 35: Number of Products by Stage and Route of Administration, Influenza A Virus, H7N9 Subtype Infections 73
Table 36: Number of Products by Stage and Molecule Type, Influenza A Virus, H7N9 Subtype Infections 74
Table 37: Influenza A Virus, H3N2 Subtype Infections – Pipeline by AbbVie Inc 75
Table 38: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Adimmune Corp 76
Table 39: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Aphios Corp 76
Table 40: Influenza A Virus, H3N2 Subtype Infections – Pipeline by AusBio Ltd 77
Table 41: Influenza A Virus, H3N2 Subtype Infections – Pipeline by BioCryst Pharmaceuticals Inc 77
Table 42: Influenza A Virus, H3N2 Subtype Infections – Pipeline by BiondVax Pharmaceuticals Ltd 78
Table 43: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Cadila Healthcare Ltd 78
Table 44: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Celltrion Inc 79
Table 45: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Emergent BioSolutions Inc 80
Table 46: Influenza A Virus, H3N2 Subtype Infections – Pipeline by FluGen Inc 80
Table 47: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Inovio Pharmaceuticals Inc 81
Table 48: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd 81
Table 49: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Johnson & Johnson 82
Table 50: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Medicago Inc 83
Table 51: Influenza A Virus, H3N2 Subtype Infections – Pipeline by MedImmune LLC 83
Table 52: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Mucosis BV (Inactive) 84
Table 53: Influenza A Virus, H3N2 Subtype Infections – Pipeline by NanoViricides Inc 84
Table 54: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Novavax Inc 85
Table 55: Influenza A Virus, H3N2 Subtype Infections – Pipeline by OPKO Health Inc 85
Table 56: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Sanofi 86
Table 57: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Sanofi Pasteur SA 87
Table 58: Influenza A Virus, H3N2 Subtype Infections – Pipeline by Sarepta Therapeutics Inc 87
Table 59: Influenza A Virus, H3N2 Subtype Infections – Pipeline by SK Chemicals Co Ltd 88
Table 60: Influenza A Virus, H3N2 Subtype Infections – Pipeline by VBI Vaccines Inc 88
Table 61: Influenza A Virus, H1N1 Subtype Infections – Pipeline by AbbVie Inc 89

List of Figures
1.2 List of Figures
Figure 1: Number of Products under Development for Influenza A Virus, H3N2 Subtype Infections 11
Figure 2: Number of Products under Development by Companies, Influenza A Virus, H3N2 Subtype Infections 12
Figure 3: Number of Products under Development by Universities/Institutes Influenza A Virus, H3N2 Subtype Infections 14
Figure 4: Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections 19
Figure 5: Number of Products under Development by Companies, Influenza A Virus, H1N1 Subtype Infections 20
Figure 6: Number of Products under Development by Universities/Institutes, Influenza A Virus, H1N1 Subtype Infections 23
Figure 7: Number of Products under Development for Influenza A Virus, H5N1 Subtype Infections 31
Figure 8: Number of Products under Development by Companies, Influenza A Virus, H5N1 Subtype Infections 33
Figure 9: Number of Products under Development by Universities/Institutes, Influenza A Virus, H5N1 Subtype Infections 36
Figure 10: Number of Products under Development for Influenza A Virus, H7N9 Subtype Infections 41
Figure 11: Number of Products under Development by Companies, Influenza A Virus, H7N9 Subtype Infections 42
Figure 12: Number of Products under Development by Universities/Institutes, Influenza A Virus, H7N9 Subtype Infections 44
Figure 13: Number of Products by Top 10 Targets, Influenza A Virus, H3N2 Subtype Infections 48
Figure 14: Number of Products by Stage and Top 10 Targets, Influenza A Virus, H3N2 Subtype Infections 48
Figure 15: Number of Products by Top 10 Mechanism of Actions, Influenza A Virus, H3N2 Subtype Infections 50
Figure 16: Number of Products by Stage and Top 10 Mechanism of Actions, Influenza A Virus, H3N2 Subtype Infections 50
Figure 17: Number of Products by Routes of Administration, Influenza A Virus, H3N2 Subtype Infections 52
Figure 18: Number of Products by Stage and Routes of Administration, Influenza A Virus, H3N2 Subtype Infections 52
Figure 19: Number of Products by Top 10 Molecule Types, Influenza A Virus, H3N2 Subtype Infections 54
Figure 20: Number of Products by Stage and Top 10 Molecule Types, Influenza A Virus, H3N2 Subtype Infections 54
Figure 21: Number of Products by Top 10 Targets, Influenza A Virus, H3N2 Subtype Infections 55
Figure 22: Number of Products by Stage and Top 10 Targets, Influenza A Virus, H3N2 Subtype Infections 56
Figure 23: Number of Products by Top 10 Mechanism of Actions, Influenza A Virus, H3N2 Subtype Infections 57
Figure 24: Number of Products by Stage and Top 10 Mechanism of Actions, Influenza A Virus, H3N2 Subtype Infections 57
Figure 25: Number of Products by Top 10 Routes of Administration, Influenza A Virus, H3N2 Subtype Infections 59
Figure 26: Number of Products by Stage and Top 10 Routes of Administration, Influenza A Virus, H3N2 Subtype Infections 59
Figure 27: Number of Products by Top 10 Molecule Types, Influenza A Virus, H3N2 Subtype Infections 61
Figure 28: Number of Products by Stage and Top 10 Molecule Types, Influenza A Virus, H3N2 Subtype Infections 61
Figure 29: Number of Products by Top 10 Targets, Influenza A Virus, H5N1 Subtype Infections 62
Figure 30: Number of Products by Stage and Top 10 Targets, Influenza A Virus, H5N1 Subtype Infections 63
Figure 31: Number of Products by Top 10 Mechanism of Actions, Influenza A Virus, H5N1 Subtype Infections 64
Figure 32: Number of Products by Stage and Top 10 Mechanism of Actions, Influenza A Virus, H5N1 Subtype Infections 64
Figure 33: Number of Products by Routes of Administration, Influenza A Virus, H5N1 Subtype Infections 66
Figure 34: Number of Products by Stage and Routes of Administration, Influenza A Virus, H5N1 Subtype Infections 66
Figure 35: Number of Products by Top 10 Molecule Types, Influenza A Virus, H5N1 Subtype Infections 67
Figure 36: Number of Products by Stage and Top 10 Molecule Types, Influenza A Virus, H5N1 Subtype Infections 68
Figure 37: Number of Products by Targets, Influenza A Virus, H7N9 Subtype Infections 69
Figure 38: Number of Products by Stage and Targets, Influenza A Virus, H7N9 Subtype Infections 69
Figure 39: Number of Products by Mechanism of Actions, Influenza A Virus, H7N9 Subtype Infections 70
Figure 40: Number of Products by Stage and Mechanism of Actions, Influenza A Virus, H7N9 Subtype Infections 71
Figure 41: Number of Products by Routes of Administration, Influenza A Virus, H7N9 Subtype Infections 72
Figure 42: Number of Products by Stage and Routes of Administration, Influenza A Virus, H7N9 Subtype Infections 72
Figure 43: Number of Products by Molecule Types, Influenza A Virus, H7N9 Subtype Infections 73
Figure 44: Number of Products by Stage and Molecule Types, Influenza A Virus, H7N9 Subtype Infections 74